Showing results (1-10 of 415) with videos related to
Sort By:
Pageof 42
Obesity (Silver Spring, Md.)|December 11, 2022
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsIldiko Lingvay, Kirstine Brown-Frandsen, Helen M Colhoun, et al.The New England Journal of Medicine|November 12, 2023
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesA Michael Lincoff, Kirstine Brown-Frandsen, Helen M Colhoun, et al.Journal of Thrombosis and Haemostasis : JTH|May 25, 2019
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical programGallia G Levy, Elina Asikanius, Peter Kuebler, et al.American Heart Journal|October 18, 2003
Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?A Michael LincoffCleveland Clinic Journal of Medicine|April 3, 2014
Managing acute coronary syndromes: decades of progressA Michael LincoffReviews in Cardiovascular Medicine|November 20, 2002
Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarctionA Michael LincoffCleveland Clinic Journal of Medicine|September 13, 2016
Dual antiplatelet therapy for acute coronary syndromes: How long to continue?Meghana Halkar, A Michael LincoffEndocrinology and Metabolism Clinics of North America|August 14, 2016
Guidelines for Obesity ManagementDonna H RyanPageof 42